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NF-κB pathway controls mitochondrial dynamics
M Laforge1, V Rodrigues1,2, R Silvestre3, C Gautier4,5,6, R Weil7, O Corti4,5,6 and J Estaquier*,1,8
The Optic atrophy 1 protein (OPA1) is a key element in the dynamics and morphology of mitochondria. We demonstrated that the
absence of IκB kinase-α, which is a key element of the nonclassical NF-κB pathway, has an impact on the mitochondrial network
morphology and OPA1 expression. In contrast, the absence of NF-κB essential modulator (NEMO) or IκB kinase-β, both of which
are essential for the canonical NF-κB pathway, has no impact on mitochondrial dynamics. Whereas Parkin has been reported to
positively regulate the expression of OPA1 through NEMO, herein we found that PARK2 overexpression did not modify the
expression of OPA1. PARK2 expression reduced the levels of Bax, and it prevented stress-induced cell death only in Bak-deficient
mouse embryonic fibroblast cells. Collectively, our results point out a role of the nonclassical NF-κB pathway in the regulation of
mitochondrial dynamics and OPA1 expression.
Cell Death and Differentiation (2016) 23, 89–98; doi:10.1038/cdd.2015.42; published online 29 May 2015
Mitochondria perform multiple functions that are critical to the
maintenance of cellular homeostasis. Mitochondrial dysfunc-
tions have been linked to the development of degenerative
diseases and aging. Damaged mitochondria are removed by
mitophagy, a process partially regulated by the PARK2-
encoded E3 ubiquitin ligase (Parkin) in a PTEN-induced
putative protein kinase 1 (PINK1)-dependent manner.1–4
During mitophagy, the phosphorylation of mitofusin (Mfn) 2
by PINK1 has been suggested to induce the recruitment of
Parkin to the mitochondria in cardiomyocytes.5 However,
previous groups have shown that that Mfn 1 and 2 are
dispensable for Parkin-dependent mitophagy in fibroblasts,
whereas the Parkin-dependent degradation of these proteins
may impair fusion of damaged mitochondria with the healthy
network.6–8 PINK1 and Parkin thus act as a quality control
machinery on the outer mitochondrial membrane (OMM) to
preserve mitochondrial integrity through the ubiquitination of
OMM proteins.9,10 Moreover, through its E3 ubiquitin ligase
activity,11,12 Parkin was reported to bind to the linear ubiquitin
chain assembly complex (LUBAC) and to increase the
ubiquitination of NF-κB essential modulator (NEMO),13 a
component of the classical NF-κB signaling pathway.14
Müller–Rischart et al. also proposed that Parkin positively
regulates the expression of the mitochondrial guanosine
triphosphatase Optic atrophy 1 protein (OPA1) through linear
ubiquitination of NEMO.13 OPA1 is a regulator of mitochondrial
inner membrane fusion and cristae remodeling.15–17 A defect
in OPA1 expression is associated with mitochondrial network
fragmentation and enhanced sensitivity of the cells to undergo
apoptosis by promoting cytochrome c release from
the mitochondria.18–20 Because NEMO-deficient mouse
embryonic fibroblast (MEF) cells display a normal mitochon-
drial network morphology, we decided to re-examine the role
of Parkin in regulating OPA1 expression through the NF-κB
signaling pathway.
Results and discussion
Overexpression of Park2 is not associated with higher
levels of OPA1. On the basis of the observation that
NEMO-deficient MEF cells display a mitochondrial network
morphology without fragmentation (Figure 1a) and exhibit the
same levels of OPA1 isoforms in comparison with wild-type
(WT) MEF cells (Figure 1b), we analyzed the mitochondrial
network in Parkin-deficient MEF cells (Figure 1c). Confocal
microscopy revealed a decrease in the size of mitochondria,
although mantaining similar numbers per cell when com-
pared with WT MEF cells (Figures 1c–e). Previous reports
from fibroblasts of patients with PARK2 mutations showed
similar degrees of branching under basal culturing
conditions.21,22 In the presence of protonophore carbonyl
cyanide 3-chlorophenylhydrazone (CCCP), mitochondrial
network is fragmented in Parkin-deficient cells (Figure 1d).
Analysis of OPA1 expression in Parkin-deficient
cells revealed a decrease of ~ 24% in the amount of OPA1
compared with WT cells (Figure 1f), in agreement with
Müller–Rischart et al.13
To further examine the role of Parkin in OPA1 regulation,
we cotransfected WT, Parkin-, and NEMO-deficient MEF cells
with an expression plasmid for PARK2 and a GFP plasmid to
monitor the percentage of transfected cells. We achieved
a cell transfection efficiency of ~ 40%, as quantified by flow
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cytometry at 24 h (Figure 2a). Parkin expression was
assessed by western blotting, and actin was used as a control
for loading. Analysis of OPA1 expression in PARK2-trans-
fected cells did not reveal an increase in the amount of OPA1 in
WT and Parkin− /− (Figures 2b and c). In NEMO-deficient
MEFs such as WT or Parkin-deficient MEFs, the overexpres-
sion of Parkin following transfection at a dose of 1 μg of
plasmid rather resulted in a decrease, although not significant,
in the amount of OPA1 (Figure 2d). Because Müller–Rischart
et al.13 reported a significant upregulation in protein levels
of OPA1, both under basal conditions and in the presence of
CCCP, we treated WT- and NEMO-deficient MEF cells
with CCCP (Figure 3). CCCP induced the degradation
of the long isoform of OPA1 (Figures 3a and b), as previously
described.15,16,18–20 In the presence of Parkin, no difference in
the levels of OPA1 was observed either at 3 or 24 h post
Figure 1 Mitochondrial morphology and OPA1 expression in NEMO- and Parkin-deficient MEF cells. (a) WT and NEMO− /− cells were stained with specific antibodies
directed against cytochrome c (Cyt c, in green) and Hsp60 (in red). (b) OPA1 profile in WTand NEMO− /−. Immunoblot was probed with specific OPA1 antibodies. Hsp60 was
used as a loading control to normalize protein content. Results correspond to the mean of three experiments. (c) Mitochondrial network in WTand Parkin− /− cells. MEFs were
stained with MitoTracker Green and imaged on an inverted microscope to obtain raw epifluorescence images (left panels). Deconvolved images (center panels) were obtained by
subtracting a Gaussian blur (σ: 12) to the original images. Deconvolved images were then thresholded to obtain a binary image of the mitochondrial network (right panels) used for
the automatized analysis of the size and the number of mitochondria in each individual cell. (d and e) Bar graphs showing (d) the average number and (e) the average size of
mitochondria in WTand Parkin− /− MEFs in the absence or presence of CCCP (n= 130, 136, and 120, respectively). (f) OPA1 profile in WTand Parkin− /− MEFs. Immunoblot
was probed with specific OPA1 antibodies. Hsp60 was used as a loading control to normalize protein content. Results are from three experiments, *Po0.05
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treatment (Figures 3a and b). This result is consistent with a
previous report from Lutz et al. showing that the absence of
parkin does not alter the proteolytic processing of OPA1 in SH-
SY5Y cells.23 It has been proposed that mitochondrial fission
related to Drp1 induces mitochondrial network fragmentation
in Parkin-deficient cells.23 Furthermore, in both cell lines,
CCCP induced mitochondrial network fragmentation (Figures
3c and d) and dissipation of mitochondrial membrane
potential (ΔΨm loss) (Figures 3e and f). Moreover, in the
presence of Parkin, the mitochondrial membrane potential of
CCCP-treated MEF is even reduced, suggesting a removal of
damaged mitochondria (Figures 3c and f), which is consistent
with previous reports on the functional role of Parkin on
mitochondria.6,7
IKKα-deficient MEF cells display lower levels of OPA1 and a
fragmented mitochondrial network. The NF-κB/Rel family is
composed of several members, including RelA (p65), RelB,
c-Rel, NF-κB1 p50, and NF-κB2 p52.14 NF-κB proteins are
regulated through their interaction with specific inhibitors, the
IκB proteins (IκBα, IκBβ, or IκBε), which keep them in an
inactive form in the cytoplasm of cells. The classical NF-κB
pathway involves a huge complex containing NEMO and
IκB kinase-β (IKKβ), but not IκB kinase-α (IKKα). IKKα
and IKKβ phosphorylate IκB proteins, which trigger their
Figure 2 OPA1 protein expression in Parkin-tranfected MEF cells. (a) Efficiency of cell transfection. Cells were cotransfected with Parkin and GFP (1 μg) or mock. Green
fluorescent intensity was determined by flow cytometry after 24 h (b–d). Profile of OPA1 expression in WT, Parkin− /−, and NEMO− /−MEFs (left panels), and quantification of the
amount of OPA1 isoforms (right panels). The values indicate the relative levels of the long isoforms with respect to the baseline (value 1), in the absence (none) or after 24 h of
transfection with either a GFPor PARK2 vector at the dose of 0.5 and 1 μg. HSP60 was used as a loading control to normalize protein content. Immunoblots were also probed with
specific Parkin antibodies. Actin was used as a loading control. Four experiments were performed
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proteasome-dependent degradation. An alternative nonclas-
sical pathway depends on IKKα and NF-κB-inducing kinase.
Our results showed that, in contrast to NEMO-deficient cells
(Figure 1), the amount of long and short isoforms of OPA1 was
drastically decreased in IKKα- and IKKαβ-deficient MEFs but
not in IKKβ-deficient MEFs (Figures 4a and b). In addition,
IKKα- and IKKαβ-deficient MEFs displayed a fragmented
mitochondrial network (Figures 4c and d), in the absence of
OMM permeabilization, as judged by cytochrome c release
(Figures 4c and d). Furthermore, we demonstrated in
both IKKα- and IKKαβ-deficient MEFs that mitochondrial
network is recovered (Figures 5a and b) and OPA1 expression
(Figures 5c and d) after the overexpression of IKKα but not
after IKKβ or NEMO expressions.
To gain further insight into the role of Parkin in the regulation
of OPA1 expression through the classical and nonclassical
NF-kB pathways, we analyzed the impact of PARK2 over-
expression in MEFs deficient for either IKKα, IKKβ, or both.14
Our western blot results showed that, in none of the MEFs
tested, transfection with the PARK2 vector, at a dose of 0.5 or
1 μg, did significantly increase the amount of OPA1 normalized
to mitochondrial HSP60 levels (Figures 6a–c). Furthermore,
we did not observe major changes in OPA1mRNA expression
by RT-PCR after transfection with thePARK2 vector compared
Figure 3 Park2 overexpression in stressed MEF cells. (a) Profile of OPA1 expression in WTand (b) NEMO− /− MEFs. Cells were transfected with Park2 at a dose of 1 μg.
OPA1 expression was assessed at 3 and 24 h in the absence or presence of CCCP. Hsp60 and actin were used as loading controls to normalize protein content. (c) WTand (d)
NEMO− /− MEF cells were stained with specific antibodies directed against Hsp60 (in red). Mitochondrial network was analyzed after overexpression of Park2 in the absence or
presence of CCCP after 24 h. (e) Mitochondrial membrane potential of WT MEF cells assessed by flow cytometry in the absence or presence of CCCP. (f) Histograms of ΔΨm
from WTand NEMO− /− MEF cells (mean fluorescence intensity) of transfected Park2 cells in the absence or presence of CCCP. Mean±SD of three independent experiments;
*Po0.05
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with the GFP vector alone in all the MEFs tested (Figure 6d).
Therefore, by using different cell lines, we excluded an impact
of cell culture conditions on the absence of Parkin effect on
OPA1 expression. Thus, overexpression of Parkin appeared to
have a minor role in regulating OPA1 expression in MEF cells.
This is in agreement with a previous report,6 in which the
overexpression of Parkin in Hela cells was not associated with
an increase in the amount of OPA1.
Overexpression of Park2 reduces Bax expression and
cell death. To delineate the role of Parkin in apoptosis, we
analyzed the effect of its overproduction in the different MEF
lines on the expression of two proapoptotic molecules with a
crucial role in the control of mitochondria permeabilization,
Bax, and Bak.24 Our results revealed that, at the dose of 1 μg
of PARK2 vector, the amount of Bax normalized to actin was
lower in WT, Parkin-deficient, and IKKαβ-deficient MEFs than
Figure 4 Mitochondrial fragmentation and OPA1 loss in IKKα- and IKKαβ-deficient MEFs. (a) OPA1 profile in WT, IKKαβ− /−, IKKα− /−, and IKKβ− /− MEFs. Immunoblot
was probed with specific OPA1 antibodies. Hsp60 was used as loading control to normalize protein content. (b) Results correspond to the mean of three experiments. *Po0.05
compared with WTand IKKβ− /−MEF cells. (c) WTand in IKKαβ− /− and IKKα− /− cells were stained with specific antibodies directed against cytochrome c (Cyt c, in green) and
HSP60 (in red). (d) The histograms show the percentage of cells displaying mitochondrial fragmentation (% fragmented mitochondria) and the release and disappearance of
cytochrome c (% diffuse Cyt c). For each condition, 150 cells were analyzed. Mean± S.D. of three independent experiments; *Po0.05
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in nontransfected cells or in cells transfected with a GFP
vector (Figures 7a and c). We did not observe differences in
the amount of Bak in any of the cell lines following
overexpression of Parkin.
Finally, we assessed whether the ectopic expression of
Parkin protected WTor PARK2-deficient MEFs from cell death
induced by staurosporine (STS) (Figure 8). Ectopic expres-
sion of Parkin in MEF cells had no protective effect against
STS-mediated cell death inWT (Figures 8a and b) or in Parkin-
deficient MEFs (Figure 8c). Because in MEF cells Bax and
Bak are functionally redundant in regulating apoptosis,25 the
reduction in the amount of Bax is probably not sufficient to
provide protection in these conditions. These results are
consistent with an early report showing that Parkin had aminor
effect on a large panel of apoptotic stimuli including STS.26
The protective effect of Parkin observed in neuronal cells by
Johnson et al. in similar conditions27 probably reflects the fact
that Bax is essential to prevent death in neurons, whereas Bak
has no role.28,29 Therefore, we assessed PARK2 overexpres-
sion in Bak-deficient MEF cells (Figures 8d and e). In this
Figure 5 Mitochondrial network fragmentation and OPA1 expression. (a, c) IKKαβ− /− and (b, d) IKKα− /− MEF cells were transfected with plasmids encoding for IKKα,
IKKβ, NEMO, or both IKKα+IKKβ at the dose of 1 μg, mock serves as a control. (a and b) After overnight culture, cells were stained with specific antibodies directed against
HSP60 (in red) and mitochondrial fragmentation was analyzed (c and d) OPA1 expression. As control Hsp60 was used as loading control to normalize protein content.
Furthermore immunoblots were probed with specific antibodies to IKKα, IKKβ, and NEMO. Actin was used as a control. Mean± S.D. of three independent experiments; *Po0.05
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context, our results demonstrated a protective effect of Parkin
on STS-mediated mitochondrial depolarization (Figure 8d)
and cell death (Figure 8e). This effect was not dependent on
the dose used, as in a recent report the authors show that at
the dose of 20 μg, which is 20-fold higher than the dose used
here, Park2 overexpression favors cell death.30
Conclusions
In conclusion, our results demonstrate that despite a decrease
in the level of OPA1, associated with reductions in mitochon-
drial network in Parkin-deficient cells, PARK2 overexpression
had no impact on the expression of OPA1 in MEF cells. Thus,
these findings do not confirm the major role of Parkin in OPA1
Figure 6 OPA1 expression in Parkin-transfected MEF cells. (a) IKKα− /−, (b) IKKβ− /−, and (c) IKKαβ− /−. MEFs were cotransfected with vectors encoding PARK2, GFP, or
mock. The values indicate the relative levels of the long isoforms with respect to the baseline (value 1), in the absence (mock) or after 24 h of transfection with either GFP
or PARK2 at the dose of 0.5 and 1 μg. HSP60 was used as a loading control to normalize protein content. Immunoblots were also probed with specific Parkin antibodies. Actin
was used as a loading control. Four experiments were performed. (d) mRNA expression of OPA1 in Parkin–transfected MEF cells. RT-PCRs were performed in WT,
IKKα− /−, NEMO− /−, IKKαβ− /−, and Parkin− /−. The values indicate the relative gene expression of OPA1 with respect to the GFP baseline (value set as 1). Two experiments
were performed
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regulation reported by Müller–Rischart.13 As Bax has a
preponderant role over Bak in primary neurons, the protective
effect of Parkin may rather be related to the ubiquitination of Bax
and the limitation of its mitochondrial translocation to the
mitochondria, previously reported to dampen the apoptotic
response.31 By showing that the absence of IKKα, with or without
IKKβ, has an impact on mitochondrial network morphology and
OPA1 expression, our results point out a role of the nonclassical
NF-κB pathway in the regulation of mitochondrial dynamics and
OPA1 expression, rather than to a role of NEMO, which is
essential for the canonical NF-κB pathway.
Materials and Methods
Cell culture and reagents. MEF (WT, NEMO− /−, IKKα− /−, IKKβ− /−,
IKKαβ− /−, and Parkin− /−) cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM; Invitrogen, Carlsbad, NM, USA), supplemented with 10% fetal calf serum,
2 mM L-glutamine, 50 IU penicillin, and 50 μg/ml streptomycin in 5% CO2, at 37 °C.
MEF cells were transfected using lipofectamine2000 (Invitrogen) with plasmids
encoding for either GFP or PARK2 plasmid. STS was purchased from Sigma
(La Chapelle-sur-Erdre, France).
Flow cytometry. After 24 h, Parkin-transfected cells were treated overnight
with STS. Cells were also cotransfected with GFP, and the percentage of dying cells
was assessed using a propidium iodide nuclear probe (PI+, Molecular Probes, Life
Technology, Cergy Pontoise, France). Mitochondrial membrane potential was
assessed using DioC6 (Molecular Probes). Cells were analyzed by flow cytometry
(FC500 flow cytometer, Beckman Coulter, Villepinte, France).
Real-time PCR analysis. Total RNA was isolated from the different MEF cell
lines after 24 h of transfection. cDNA synthesis was performed using the
AffinityScript QPCR cDNA Synthesis Kit (Stratagene, Agilent Technologies, Paris,
France) with 1 μg of total RNA and random primers. The resulting complementary-
DNA product was expanded using the Absolute Blue QPCR SYBR Green ROX Mix
(Thermo Scientific, Illkirch, France) with specific primers for murine OPA1 (forward:
5′-ACCACAGGAAGCTCAAGAAATC-3′, reverse: 5′-TCTGATCTCCAACCACAAC
AAC-3′). Sample input was normalized through quantification of the transcript
levels of the housekeeping genes Gapdh (forward: 5′- GGCTCATGACCACAGTCC
-3′, reverse: 5′-GCAGGGATGATGTTCTGG-3′) and Rps18 (forward: 5′-GGAAG
TACAGCCAGGTTCTG-3′, reverse: 5′-GTGGTCTTGGTGTGCTGAC-3′). Detection
was performed with the ABI PRISM 7900HT Sequence Detection System (Applied
Biosystems, Saint Aubin, France). Threshold cycle (Ct) values were obtained for
each gene using the instrument software and auto-Ct function. The relative levels of
gene expression were determined using the delta–delta Ct method.
Immunoblotting. Total lysates were extracted using 1% NP40 (150 mM NaCl,
50 mM Tris HCl pH 7.4, 10 mM EDTA) supplemented by a cocktail of antiproteases
and antiphosphatases. A total of 20 μg of proteins from each point were resolved by
SDS-NuPAGE (4–12% Bis-Tris gels, Novex, Les Ulis, France) and transferred to
Figure 7 Modulation of Bax and Bak expressions in Parkin-transfected MEF cells. Immunoblots from (a) WT, (b) Parkin− /− and (c) Ikkαβ− /− as described in Figure 2 and
Figure 6 were probed with Bax and Bak antibodies. Values indicate Bax and Bak levels with respect to the baseline (mock, value set as 1) and to actin as a control of loading.
Histograms represent mean±S.D. of three independent experiments; *Po0.05
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nitrocellulose membranes (Amersham Biosciences, Les Ulis, France). Nonspecific
sites were blocked by incubation with 5% milk for 1 h at room temperature, and the
membranes were then incubated with mouse monoclonal anti-OPA1 (BD
Biosciences Pharmingen, Le Pont de Claix, France; clone 18), anti-Parkin
(Millipore, Le Pont de Claix, France), and rabbit anti-Bax (N-20, from Santa-Cruz,
Le Pont de Claix, France). Antibodies specific for IKKα, IKKβ, and NEMO were
purchased from Cell Signaling (St Quentin Fallavier, France). Equal protein loading
was assessed by probing the membranes with anti-actin (Millipore) and anti-HSP60
monoclonal antibodies (Stressgen, St Quentin Fallavier, France). Membranes were
treated with horseradish peroxidase-linked goat anti-mouse or anti-rabbit secondary
antibodies (Amersham Biosciences). Immunoreactive proteins were detected and
quantified by enhanced chemiluminescence (Amersham Biosciences) using a CCD
camera (GBOX, SYNGENE, Ozyme, France).
Fluorescence microscopy. MEF cells were grown on coverslips and fixed
with 4% paraformaldehyde (Sigma-Aldrich, St Quentin Fallavier, France). Cells were
incubated for 1 h in blocking buffer (2% bovine serum albumin in phosphate-buffered
saline) and then overnight with a mouse monoclonal anti-cytochrome c (BD
Biosciences, St Quentin Fallavier, France; clone 6H2.B4), or goat anti-HSP60
(Santa Cruz) antibody. Cells were washed and incubated for 2 h with Alexa Fluor
secondary anti-mouse, anti-rabbit, or anti-goat antibodies (Molecular Probes).
Images were acquired with a Zeiss LSM 510 confocal microscope equipped with an
oil-immersion fluorescence objective (Carl Zeiss, Inc., Périgny, France). Cells were
also stained with 100 nM Mitotracker green (Invitrogen) for 30 min. Cells were
imaged by epifluorescence using a Zeiss Axiovert 200 M inverted microscope.
Images were then analyzed using the imageJ software (NIH, Bethesda, MD, USA).
Deconvolution was performed by subtracting a Gaussian blur (σ: 12) to the original
image. Deconvolved images were then processed with a certain threshold to obtain
a binary image of the mitochondrial network. The binary image was then analyzed
using the Analyze Particle function of ImageJ to determine the number and the size
of mitochondria in individual cells.
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